Financhill
Buy
74

CTEV Quote, Financials, Valuation and Earnings

Last price:
$38.75
Seasonality move :
-18.34%
Day range:
$35.09 - $38.90
52-week range:
$4.80 - $38.90
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.67x
P/B ratio:
42.63x
Volume:
238.1K
Avg. volume:
81.1K
1-year change:
77.98%
Market cap:
$632M
Revenue:
$930.6M
EPS (TTM):
-$72.72

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
CTEV
Claritev
$222.7M -$2.20 -1.76% -93.41% $34.50
DRIO
DarioHealth
$7.5M -$0.06 10.39% -29.16% $2.38
FOXO
FOXO Technologies
-- -- -- -- --
OTRK
Ontrak
$3.4M -- -13% -- $4.00
SPOK
Spok Holdings
$34M $0.24 3% 18.18% $20.00
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
CTEV
Claritev
$38.45 $34.50 $632M -- $0.00 0% 0.67x
DRIO
DarioHealth
$0.72 $2.38 $31.4M -- $0.00 0% 1.06x
FOXO
FOXO Technologies
$0.40 -- $2.6M -- $0.00 0% 0.11x
OTRK
Ontrak
$1.47 $4.00 $6.2M -- $0.00 0% 0.72x
SPOK
Spok Holdings
$16.20 $20.00 $333.3M 20.77x $0.31 7.72% 2.40x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
CTEV
Claritev
99.68% -5.079 1360.84% 0.77x
DRIO
DarioHealth
28.37% -0.894 111.66% 1.76x
FOXO
FOXO Technologies
38.2% 17.122 144.44% 0.09x
OTRK
Ontrak
67.21% -0.416 155.76% 0.50x
SPOK
Spok Holdings
-- 0.393 -- 0.99x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
CTEV
Claritev
$170.9M $9.7M -23.75% -283.02% 0.76% -$68.9M
DRIO
DarioHealth
$3.9M -$9.4M -45.31% -63.94% -139.35% -$6.7M
FOXO
FOXO Technologies
$1.3M -$1.5M -214.25% -- 8.49% -$1.3M
OTRK
Ontrak
$746K -$5.9M -144.37% -222.91% -290.04% -$2.8M
SPOK
Spok Holdings
$29.1M $6.1M 10.19% 10.19% 16.74% $1.5M

Claritev vs. Competitors

  • Which has Higher Returns CTEV or DRIO?

    DarioHealth has a net margin of -30.83% compared to Claritev's net margin of -136.66%. Claritev's return on equity of -283.02% beat DarioHealth's return on equity of -63.94%.

    Company Gross Margin Earnings Per Share Invested Capital
    CTEV
    Claritev
    73.88% -$4.38 $4.6B
    DRIO
    DarioHealth
    57.49% -$0.14 $102.9M
  • What do Analysts Say About CTEV or DRIO?

    Claritev has a consensus price target of $34.50, signalling downside risk potential of -10.27%. On the other hand DarioHealth has an analysts' consensus of $2.38 which suggests that it could grow by 232.12%. Given that DarioHealth has higher upside potential than Claritev, analysts believe DarioHealth is more attractive than Claritev.

    Company Buy Ratings Hold Ratings Sell Ratings
    CTEV
    Claritev
    0 1 0
    DRIO
    DarioHealth
    3 1 0
  • Is CTEV or DRIO More Risky?

    Claritev has a beta of 0.249, which suggesting that the stock is 75.051% less volatile than S&P 500. In comparison DarioHealth has a beta of 1.552, suggesting its more volatile than the S&P 500 by 55.239%.

  • Which is a Better Dividend Stock CTEV or DRIO?

    Claritev has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Claritev pays -- of its earnings as a dividend. DarioHealth pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CTEV or DRIO?

    Claritev quarterly revenues are $231.3M, which are larger than DarioHealth quarterly revenues of $6.8M. Claritev's net income of -$71.3M is lower than DarioHealth's net income of -$9.2M. Notably, Claritev's price-to-earnings ratio is -- while DarioHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Claritev is 0.67x versus 1.06x for DarioHealth. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTEV
    Claritev
    0.67x -- $231.3M -$71.3M
    DRIO
    DarioHealth
    1.06x -- $6.8M -$9.2M
  • Which has Higher Returns CTEV or FOXO?

    FOXO Technologies has a net margin of -30.83% compared to Claritev's net margin of -19.45%. Claritev's return on equity of -283.02% beat FOXO Technologies's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CTEV
    Claritev
    73.88% -$4.38 $4.6B
    FOXO
    FOXO Technologies
    39.94% -$0.37 $15.7M
  • What do Analysts Say About CTEV or FOXO?

    Claritev has a consensus price target of $34.50, signalling downside risk potential of -10.27%. On the other hand FOXO Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that Claritev has higher upside potential than FOXO Technologies, analysts believe Claritev is more attractive than FOXO Technologies.

    Company Buy Ratings Hold Ratings Sell Ratings
    CTEV
    Claritev
    0 1 0
    FOXO
    FOXO Technologies
    0 0 0
  • Is CTEV or FOXO More Risky?

    Claritev has a beta of 0.249, which suggesting that the stock is 75.051% less volatile than S&P 500. In comparison FOXO Technologies has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock CTEV or FOXO?

    Claritev has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. FOXO Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Claritev pays -- of its earnings as a dividend. FOXO Technologies pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CTEV or FOXO?

    Claritev quarterly revenues are $231.3M, which are larger than FOXO Technologies quarterly revenues of $3.2M. Claritev's net income of -$71.3M is lower than FOXO Technologies's net income of -$616.5K. Notably, Claritev's price-to-earnings ratio is -- while FOXO Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Claritev is 0.67x versus 0.11x for FOXO Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTEV
    Claritev
    0.67x -- $231.3M -$71.3M
    FOXO
    FOXO Technologies
    0.11x -- $3.2M -$616.5K
  • Which has Higher Returns CTEV or OTRK?

    Ontrak has a net margin of -30.83% compared to Claritev's net margin of -341.65%. Claritev's return on equity of -283.02% beat Ontrak's return on equity of -222.91%.

    Company Gross Margin Earnings Per Share Invested Capital
    CTEV
    Claritev
    73.88% -$4.38 $4.6B
    OTRK
    Ontrak
    36.99% -$1.65 $14.2M
  • What do Analysts Say About CTEV or OTRK?

    Claritev has a consensus price target of $34.50, signalling downside risk potential of -10.27%. On the other hand Ontrak has an analysts' consensus of $4.00 which suggests that it could grow by 172.11%. Given that Ontrak has higher upside potential than Claritev, analysts believe Ontrak is more attractive than Claritev.

    Company Buy Ratings Hold Ratings Sell Ratings
    CTEV
    Claritev
    0 1 0
    OTRK
    Ontrak
    0 0 0
  • Is CTEV or OTRK More Risky?

    Claritev has a beta of 0.249, which suggesting that the stock is 75.051% less volatile than S&P 500. In comparison Ontrak has a beta of 2.298, suggesting its more volatile than the S&P 500 by 129.787%.

  • Which is a Better Dividend Stock CTEV or OTRK?

    Claritev has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ontrak offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Claritev pays -- of its earnings as a dividend. Ontrak pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CTEV or OTRK?

    Claritev quarterly revenues are $231.3M, which are larger than Ontrak quarterly revenues of $2M. Claritev's net income of -$71.3M is lower than Ontrak's net income of -$6.9M. Notably, Claritev's price-to-earnings ratio is -- while Ontrak's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Claritev is 0.67x versus 0.72x for Ontrak. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTEV
    Claritev
    0.67x -- $231.3M -$71.3M
    OTRK
    Ontrak
    0.72x -- $2M -$6.9M
  • Which has Higher Returns CTEV or SPOK?

    Spok Holdings has a net margin of -30.83% compared to Claritev's net margin of 14.32%. Claritev's return on equity of -283.02% beat Spok Holdings's return on equity of 10.19%.

    Company Gross Margin Earnings Per Share Invested Capital
    CTEV
    Claritev
    73.88% -$4.38 $4.6B
    SPOK
    Spok Holdings
    80.13% $0.25 $151.7M
  • What do Analysts Say About CTEV or SPOK?

    Claritev has a consensus price target of $34.50, signalling downside risk potential of -10.27%. On the other hand Spok Holdings has an analysts' consensus of $20.00 which suggests that it could grow by 23.46%. Given that Spok Holdings has higher upside potential than Claritev, analysts believe Spok Holdings is more attractive than Claritev.

    Company Buy Ratings Hold Ratings Sell Ratings
    CTEV
    Claritev
    0 1 0
    SPOK
    Spok Holdings
    1 0 0
  • Is CTEV or SPOK More Risky?

    Claritev has a beta of 0.249, which suggesting that the stock is 75.051% less volatile than S&P 500. In comparison Spok Holdings has a beta of 0.515, suggesting its less volatile than the S&P 500 by 48.497%.

  • Which is a Better Dividend Stock CTEV or SPOK?

    Claritev has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings offers a yield of 7.72% to investors and pays a quarterly dividend of $0.31 per share. Claritev pays -- of its earnings as a dividend. Spok Holdings pays out 176.29% of its earnings as a dividend.

  • Which has Better Financial Ratios CTEV or SPOK?

    Claritev quarterly revenues are $231.3M, which are larger than Spok Holdings quarterly revenues of $36.3M. Claritev's net income of -$71.3M is lower than Spok Holdings's net income of $5.2M. Notably, Claritev's price-to-earnings ratio is -- while Spok Holdings's PE ratio is 20.77x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Claritev is 0.67x versus 2.40x for Spok Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CTEV
    Claritev
    0.67x -- $231.3M -$71.3M
    SPOK
    Spok Holdings
    2.40x 20.77x $36.3M $5.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Where Will Asana Stock Be in 5 Years?
Where Will Asana Stock Be in 5 Years?

Asana stock hasn’t given many investors on Wall Street any…

Where Will Dell Stock Be in 5 Years?
Where Will Dell Stock Be in 5 Years?

So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock